myRisk is proven to increase the identification of mutation carriers within the same NCCN recommended testing population.
Multiple genes can be associated with a single cancer
Multiple cancer risks can be associated with a single gene
It is now recognized through an increasing amount of published literature that the same type of cancer or family history of cancer can be caused by mutations in different genes. As well, the characteristics of one hereditary cancer syndrome can overlap with those of another syndrome. With the technological advances in molecular diagnostics, testing for these additional genes can be performed simultaneously with BRCA1 and BRCA2.
One key feature is the test result that providers and patients receive. Instead of a test result indicating only whether the patient is positive or negative for a gene mutation, the myRisk test provides a clinical decision support tool. This tool outlines patients’ cancer risks and the medical management recommendations endorsed by societal guidelines.